Target intelligence / Profile preview

Pathogenic gram-positive bacteria

Molecular classification
Other
01

Overview

Pathogenic gram-positive bacteria" is a collective description for a group of bacterial species that share both Gram stain positivity (due to a thick peptidoglycan cell wall) and the capacity to cause disease in humans. Key pathogenic genera include *Staphylococcus*, *Streptococcus*, *Enterococcus*, *Clostridium*, *Bacillus*, *Listeria*, and *Corynebacterium*. These organisms are major causes of diverse infectious diseases, such as pneumonia, sepsis, food poisoning, and wound infections. Treatments differ by species but often involve beta-lactams, glycopeptides, or other antibiotic classes targeting the bacterial cell wall or protein synthesis. The concept does not denote a precise molecular target but an organismal category relevant in clinical microbiology, infectious disease, and antibiotic therapy[2][3][4][5][6].

Other names
Pathogenic gram-positive organismsPathogenic Gram-positive cocci and bacilliGram-positive bacterial pathogens
02

Mechanism of action

Cell wall synthesis inhibition, Protein synthesis inhibition, RNA synthesis inhibition, DNA synthesis inhibition (antibiotics act by one or more of these mechanisms; most commonly cell wall synthesis inhibition due to unique thick peptidoglycan layer)

03

Biological functions

InfectionPathogenesisOther
04

Disease associations

Infection
05

Safety considerations

Antibiotic resistance (e.g., MRSA, VRE)Secondary toxicity from some toxin-producing pathogens (e.g., toxic shock, necrotizing fasciitis)Superinfection/clostridial infection with some treatmentsNosocomial infection riskDrug-specific adverse reactions due to antibiotic therapy
06

Interacting drugs

Beta-lactam antibiotics (e.g., penicillin, amoxicillin, cephalosporins)

8 more in the full profile.

07

Biomarkers

Gram stain (purple/blue by light microscopy)Bacterial culture and identificationPCR for species-specific genesAntigen tests (e.g., rapid Strep test)Specific serological markers (e.g., ASO titer for Streptococcus pyogenes)

Beyond the preview

Go deeper on Pathogenic gram-positive bacteria.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic gram-positive bacteria.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call